Top Section/Ad
Top Section/Ad
Most recent
Sfr4.9bn trade is largest European ECM deal since National Grid’s £7bn rights issue in 2024
Offer came as markets recovered and volatility fell
Abbott Laboratories plundered $20bn as it led a trio of drug companies which printed jumbo bonds as a deluge of supply in the dollar market ensured a red-hot end to the month.
More articles/Ad
More articles/Ad
More articles
-
Danish pharmaceuticals company Bavarian Nordic has announced an Nkr2.8bn (€378m) rights issue to fund its acquisition of GlaxoSmithKline’s commercial and manufacturing rights to Rabipur, a treatment for rabies, and Encepur, a vaccine against tick-borne encephalitis. -
Shares in Norwegian Air Shuttle, the Norwegian airline, fell more than 25% on Friday morning after the company scrapped its profit guidance for 2020 because of the mounting economic damage caused by the spread of the Covid-19 coronavirus.
-
In this round-up, Covid-19 infections have spread across the world at an alarming speed, the Chinese central bank did not follow its US counterpart to lower interest rates, and the media row between the two countries has deepened.
-
The Bank of England may soon tweak its macroprudential policies and introduce a new funding scheme for banks to mitigate the economic impact of the Covid-19 coronavirus epidemic on companies. The measures would help lenders at a time when they could face pressure from lower rates and rising impairments.
-
Bond issuers returned to the primary market this week showing greater resilience than many expected. The intense gyrations gripping underlying rates and equities mean that deals are likely to be far from easy to do for some time as the effects of the Covid-19 outbreak grip global markets.
-
Banks are going to play an outsized role in softening the economic impact of Covid-19 in the euro area.
